Document link: MEDICINES RECOMMENDED FOR INCLUSION IN THE PHILIPPINE NATIONAL FORMULARY (PNF) (Proponents may submit appeals to hta@doh.gov.ph until 04 January 2022 using the prescribed appeal form.) Document Preview:
Preliminary Recommendation on Emtricitabine + Tenofovir Disoproxil Fumarate fixed-dose combination as Oral Pre-Exposure Prophylaxis (PrEP)
Document link: MEDICINES RECOMMENDED FOR INCLUSION IN THE PHILIPPINE NATIONAL FORMULARY (PNF) (Proponents may submit appeals to hta@doh.gov.ph until 30 December 2021.) Document Preview:
HTAC Recommends COVID-19 Vaccine Booster and Additional dose: Guidance and Conditions on Implementation
HTAC Recommends COVID-19 Vaccine Booster and Additional dose: Guidance and Conditions on Implementation Released on 15 November 2021 Link to ES: Booster and Additional Dose Vaccination for the prevention of COVID-19 While the HTAC recognizes the primary importance of reaching high vaccination coverage for protection against hospitalization, severe disease and death due to COVID-19, HTAC released its preliminary recommendations continue reading : HTAC Recommends COVID-19 Vaccine Booster and Additional dose: Guidance and Conditions on Implementation
HTAC Guidance: COVID-19 Vaccination among the Adolescent Population
HTAC notes in a recent recommendation that the DOH can further implement COVID-19 Vaccines Pfizer-BioNTech and Moderna in adolescents aged 12-17 years old for 2022. Link to HTAC Recommendation: [Vax 2022] Pedia ES_For HTAC Link to Filipino Version: Gabay ng HTAC para sa Pagbabakuna ng Kabataang Pilipino COVID-19 Vaccines under Emergency Use Authorization (EUA) The Food and Drug Administration (FDA) issues Emergency continue reading : HTAC Guidance: COVID-19 Vaccination among the Adolescent Population